BIZTRAC BETA
Wholesale of pharmaceutical and medical goods

SLEEPMED AS

Org. no. 913068882 Limited company (AS) Arendal Incorporated 2014 Active
Ownership graph ↗
Revenue 2024 NOK 237,000
Operating profit NOK 67,000
Equity NOK 43,000
Incorporated 2014
Share capital NOK 30,000

SLEEPMED AS is registered as a limited company in Arendal, Agder with organisation number 913068882. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2014. Registered share capital is NOK 30,000, divided into 30 shares. The company's stated purpose is: “Salg av medisinsk utstyr, foredrag om helserelaterte emner, og investering i verdipapirer og eiendommer.”. The most recent filed accounts, for the 2024 financial year, show NOK 237,000 in revenue and NOK 67,000 in operating profit.

Key figures · 2024

Revenue
NOK 237,000
Operating profit
NOK 67,000
Equity
NOK 43,000
Est. value
NOK 228,000

Financial health · 2024

Liquidity
1.33
Satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
24.7%
Weak
Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns SLEEPMED AS?

SØRLANDSKLINIKKEN ØRE NESE HALS
SLEEPMED AS
NOK 237,000 rev. · NOK 67,000 profit

SLEEPMED AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about SLEEPMED AS

Who owns SLEEPMED AS?

SØRLANDSKLINIKKEN ØRE NESE HALS is the largest registered owner, with 100.0%.

What is the revenue of SLEEPMED AS?

SLEEPMED AS had revenue of NOK 237,000 in 2024.

Who is the general manager of SLEEPMED AS?

Alf Bjarne Robertsen Lilleaas is registered as general manager of SLEEPMED AS.

Where is SLEEPMED AS based?

SLEEPMED AS has its business address in Arendal.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.